Published date: Sep 26 2019

Journal Title: Sudan Journal of Medical Sciences

Issue title: Sudan JMS: Volume 14 (2019), Issue No. 3

Pages: 132–142

DOI: 10.18502/sjms.v14i3.5213

hala abdalazeemSudan

Omer Fadul EdrisSudan

Amar Mohamed IsmailSudan

Background: Researchers proved the association between inflammatory condition, high sensitive C reactive protein (hs-CRP), and cardiovascular diseases (CVDs) in type 2 diabetes mellitus (DM). Therefore, this study aimed to assess the hs-CRP level in type 2 DM patients and their relation to diabetes cardiovascular complications.

Materials and methods: In a case-control study, 205 previously diagnosed type 2 DM patients and 100 controls were included. Serum high Sensitive C Reactive Protein (hs-CRP) was estimated immune-turbidimetrically using Cobas C-311® fully automated analyzer. Also, triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL-C), and low-density lipoprotein (LDL-C) were measured.

Results: Type 2 DM patients had an increased level of hs-CRP (p-value 0.020). Females had higher levels of hs-CRP, TC, HDL-C, and LDL-C than males (p-value 0.005, 0.000, 0.000, and 0.000, respectively). Moreover, patients who received statin drugs had decreased levels of hs-CRP, TC, and LDL-C (p-value 0.030, 0.000, and 0.000, respectively). The correlation analysis revealed hs-CRP correlates positively with BMI (r: 0.56, P-value 0.000).

Conclusion: The data showed that type 2 DM patients had higher hs-CRP. Moreover, hs-CRP positively associated with BMI. Therefore, obesity might be related to CVDs in type 2 DM patient.

Keywords

High sensitive C reactive protein, cardiovascular diseases, type 2 DM, obesity, Sudan.

[1] Khodaeian M, Enayati S, Tabatabaei-Malazy O, Amoli MM. Association between genetic variants and diabetes mellitus in Iranian populations: a systematic review of observational studies. Journal of diabetes research. 2015;2015:21.

[2] Liu J, Li J, Li W-J, Wang C-M. The role of uncoupling proteins in diabetes mellitus. Journal of diabetes research. 2013;2013:7.

[3] Ozougwu J, Obimba K, Belonwu C, Unakalamba C. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of Physiology and Pathophysiology. 2013;4(4):46-57.

[4] Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.

[5] Noor S, Bushara S, Sulaiman A, Elmadhoun W, Ahmed M. Undiagnosed diabetes mellitus in rural communities in Sudan: prevalence and risk factors.. Eastern Mediterranean Health Journal. 2015;21(3):164-70.

[6] Aynalem SB, Zeleke AJ. Prevalence of Diabetes Mellitus and Its Risk Factors among Individuals Aged 15 Years and Above in Mizan-Aman Town, Southwest Ethiopia, 2016: A Cross Sectional Study. International journal of endocrinology. 2018;2018:1-7.

[7] Balla SA, Ahmed HA, Awadelkareem MA. Prevalence of diabetes, knowledge, and attitude of rural, population towards diabetes and hypoglycaemic event, Sudan 2013. Am J Health Res. 2014;2(6):356-60.

[8] Baranwal JK, Maskey R, Majhi S, Lamsal M, Baral N. Association between level of HbA1c and lipid profile in T2DM patients attending diabetic OPD at BPKIHS. Health Renaissance. 2017;13(3):16-23.

[9] Moreira TS, Hamadeh MJ. The role of vitamin D deficiency in the pathogenesis of type 2 diabetes mellitus. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism. 2010;5(4):e155-e65.

[10] Likitesh A, Prabhakar K, Reddy Prasad K. Estimation of high sensitivity c-reactive protein levels as a early marker of diabetic nephropathy. european journal of pharmaceutical and medical research.4(4):315-8.

[11] Khan MI, Usman K, Ashfaq F, Himanshu D, Ali W, Idris M. Association of Hs-CRP and HbA1C with Microalbuminuria in Type-2 Diabetic patients in North India. Biomedical Research. 2012;23(3):380-4.

[12] Patil A, Ganu J. High sensitive C-reactive protein and microalbumin in type 2 diabetes mellitus. Asian Pac J Health Sci. 2014;1(4):319-21.

[13] Sindhu S, Singh HK, Salman MT, Fatima J, Verma VK. Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients. Journal of pharmacology & pharmacotherapeutics. 2011;2(4):261-65.

[14] Mohamed RA, Musa MM, Ismail AM. High Sensitive C-Reactive Protein (hs- CRP) as Predictor Marker for Cardiovascular Disease among Vitamin D Deficient Hypertensive Patients. American J Med Med Sci. 2015;5:1-6.

[15] Clearfield MB. C-reactive protein: a new risk assessment tool for cardiovascular disease. Journal-american osteopathic association. 2005;105(9):409-16.

[16] Hayashino Y, Mashitani T, Tsujii S, Ishii H. Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]). Diabetes Care. 2014;37(11):2947-52.

[17] Bashir S, Shabbir I, Aasim M. Role of C-reactive protein as a marker for microalbuminuria in type 2 diabetics. Journal of Ayub Medical College Abbottabad. 2014;26(1):32-4.

[18] Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, Shakeri MT, Aiatollahi H. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus. Iran J Kidney Dis. 2009;3(1):12-6. 27.

[19] Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. Jama. 2013;310(19):2061- 2068.

[20] Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids in health and disease. 2014;13(1):183.

[21] Kohei K. Pathophysiology of type 2 diabetes and its treatment policy. JMAJ. 2010;53(1):41-6.

[22] Rahmanian K, Shojaei M, Jahromi AS. Relation of type 2 diabetes mellitus with gender, education, and marital status in an Iranian urban population. Reports of biochemistry & molecular biology. 2013;1(2):64-8.

[23] Momin AR, Pankaja SN, Gouri MB. Albumin/creatinine ratio, as predictor of microalbuminuria, a risk factor for nephropathy in type 2 diabetes mellitus patients. Int. J. Health Sci. Res. 2011;1:34-40.

[24] Valiollah S, Mojtaba E, Vahid I, Ali SM, editors. Association of C Reactive Protein with Insulin Resistance in Type 2 Diabetic. Proceedings of International Conference on Bioscience, Biochemistry and Bioinformatics (ICBBB 2011); 2011.

[25] Mahajan A, Tabassum R, Chavali S, Dwivedi OP, Bharadwaj M, Tandon N, et al. Highsensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. The Journal of Clinical Endocrinology & Metabolism. 2009;94(6):2123-7.

[26] Qasim AN, Budharaju V, Mehta NN, St Clair C, Farouk S, Braunstein S, et al. Gender differences in the association of C−reactive protein with coronary artery calcium in Type−2 diabetes. Clinical endocrinology. 2011;74(1):44-50.

[27] Zeqollari A, Spahiu K, Vyshka G, Çakërri L. Lipid Profile in Diabetes Mellitus Type 2 Patients in Albania and The Corellation with BMI, Hypertension, and Hepatosteatosis. Journal family medicin community health. 2014;1(4):1018.

[28] Son JW, Kim DJ, Lee CB, Oh S, Song KH, Jung CH, et al. Effects of patient−tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low−density lipoprotein cholesterol in patients with type 2 diabetes. Journal of diabetes investigation. 2013;4(5):466-74.

[29] Amanullah S, Jarari A, Govindan M. Association of hs-CRP with diabetic and nondiabetic individuals. Jordan journal of biological sciences. 2010;3(1):7-12.

[30] Bandyopadhyay R, Paul R, Basu AK, Chakraborty PP, Mitra S. Study of c reactive protein in type 2 diabetes and its relation with various complications from Eastern India. Journal of Applied Pharmaceutical Science. 2013;3(7):156-9.